SCH 442416
Alternative Names: SCH-442416Latest Information Update: 29 Oct 2009
At a glance
- Originator Schering-Plough
- Class Pyrazoles; Pyrimidines; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 28 May 2001 Preclinical development for Neurological disorders diagnosis in USA (unspecified route)